CN101732623B - Medicament for treating acute gouty arthritis and preparation method thereof - Google Patents
Medicament for treating acute gouty arthritis and preparation method thereof Download PDFInfo
- Publication number
- CN101732623B CN101732623B CN2009102205255A CN200910220525A CN101732623B CN 101732623 B CN101732623 B CN 101732623B CN 2009102205255 A CN2009102205255 A CN 2009102205255A CN 200910220525 A CN200910220525 A CN 200910220525A CN 101732623 B CN101732623 B CN 101732623B
- Authority
- CN
- China
- Prior art keywords
- kilograms
- herba
- rhizoma
- parts
- chinese medicinal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 37
- 201000005569 Gout Diseases 0.000 title claims abstract description 27
- 230000001154 acute effect Effects 0.000 title claims abstract description 26
- 206010018634 Gouty Arthritis Diseases 0.000 title claims abstract description 25
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 15
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 15
- 235000008434 ginseng Nutrition 0.000 claims abstract description 15
- 239000000454 talc Substances 0.000 claims abstract description 15
- 229910052623 talc Inorganic materials 0.000 claims abstract description 15
- 241000605447 Anemarrhena Species 0.000 claims abstract description 10
- 210000000582 semen Anatomy 0.000 claims description 28
- 241000208340 Araliaceae Species 0.000 claims description 14
- 241000628997 Flos Species 0.000 claims description 14
- 241000222640 Polyporus Species 0.000 claims description 14
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims description 14
- 235000012222 talc Nutrition 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 235000005903 Dioscorea Nutrition 0.000 claims description 9
- 241000234273 Dioscorea Species 0.000 claims description 9
- 235000000504 Dioscorea villosa Nutrition 0.000 claims description 9
- 241000245240 Lonicera Species 0.000 claims description 9
- 235000004879 dioscorea Nutrition 0.000 claims description 9
- 239000000706 filtrate Substances 0.000 claims description 4
- 238000000605 extraction Methods 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 238000003825 pressing Methods 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 3
- 238000003809 water extraction Methods 0.000 claims description 2
- 210000004369 blood Anatomy 0.000 abstract description 10
- 239000008280 blood Substances 0.000 abstract description 10
- 208000002193 Pain Diseases 0.000 abstract description 4
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 240000008918 Chaenomeles cathayensis Species 0.000 abstract 1
- 235000009810 Chaenomeles cathayensis Nutrition 0.000 abstract 1
- 244000077995 Coix lacryma jobi Species 0.000 abstract 1
- 241000745390 Lophatherum Species 0.000 abstract 1
- 241000729196 Lycopus lucidus Species 0.000 abstract 1
- 206010054949 Metaplasia Diseases 0.000 abstract 1
- QMGVPVSNSZLJIA-UHFFFAOYSA-N Nux Vomica Natural products C1C2C3C4N(C=5C6=CC=CC=5)C(=O)CC3OCC=C2CN2C1C46CC2 QMGVPVSNSZLJIA-UHFFFAOYSA-N 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 244000148137 Patrinia villosa Species 0.000 abstract 1
- 235000019109 Patrinia villosa Nutrition 0.000 abstract 1
- 240000009022 Smilax rotundifolia Species 0.000 abstract 1
- 235000003205 Smilax rotundifolia Nutrition 0.000 abstract 1
- 244000107975 Strychnos nux-vomica Species 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 229930191283 anemarrhena Natural products 0.000 abstract 1
- 230000000295 complement effect Effects 0.000 abstract 1
- 239000010440 gypsum Substances 0.000 abstract 1
- 229910052602 gypsum Inorganic materials 0.000 abstract 1
- 230000015689 metaplastic ossification Effects 0.000 abstract 1
- 230000001473 noxious effect Effects 0.000 abstract 1
- 230000001575 pathological effect Effects 0.000 abstract 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 12
- 229940079593 drug Drugs 0.000 description 12
- 230000000694 effects Effects 0.000 description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 201000010099 disease Diseases 0.000 description 7
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 6
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 6
- 235000012000 cholesterol Nutrition 0.000 description 6
- 229940116269 uric acid Drugs 0.000 description 6
- 208000037920 primary disease Diseases 0.000 description 5
- 208000006820 Arthralgia Diseases 0.000 description 4
- 108010074051 C-Reactive Protein Proteins 0.000 description 4
- 102100032752 C-reactive protein Human genes 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 210000003743 erythrocyte Anatomy 0.000 description 4
- 238000004062 sedimentation Methods 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 201000001431 Hyperuricemia Diseases 0.000 description 1
- 206010060820 Joint injury Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- OFCNXPDARWKPPY-UHFFFAOYSA-N allopurinol Chemical compound OC1=NC=NC2=C1C=NN2 OFCNXPDARWKPPY-UHFFFAOYSA-N 0.000 description 1
- 229960003459 allopurinol Drugs 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 229960001338 colchicine Drugs 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- DBABZHXKTCFAPX-UHFFFAOYSA-N probenecid Chemical compound CCCN(CCC)S(=O)(=O)C1=CC=C(C(O)=O)C=C1 DBABZHXKTCFAPX-UHFFFAOYSA-N 0.000 description 1
- 229960003081 probenecid Drugs 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- GOLXNESZZPUPJE-UHFFFAOYSA-N spiromesifen Chemical compound CC1=CC(C)=CC(C)=C1C(C(O1)=O)=C(OC(=O)CC(C)(C)C)C11CCCC1 GOLXNESZZPUPJE-UHFFFAOYSA-N 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Project | Before the treatment | After the treatment | Difference before and after the treatment |
Blood uric acid μ mol/L | 650.60±99.93 | 464.78±93.05 | (P<0.01) |
Erythrocyte sedimentation rate mm/1h | 31.65±9.34 | 21.83±18.15 | (P<0.01) |
C reactive protein mg/L | 23.68±16.33 | 9.28±11.63 | (P<0.01) |
Cholesterol mmol/L | 6.31±0.05 | 5.02±0.06 | (P<0.05) |
Cholesterol mmol/L | 2.46±0.07 | 1.43±0.07 | (P<0.05) |
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009102205255A CN101732623B (en) | 2009-12-08 | 2009-12-08 | Medicament for treating acute gouty arthritis and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009102205255A CN101732623B (en) | 2009-12-08 | 2009-12-08 | Medicament for treating acute gouty arthritis and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101732623A CN101732623A (en) | 2010-06-16 |
CN101732623B true CN101732623B (en) | 2011-05-04 |
Family
ID=42456991
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009102205255A Expired - Fee Related CN101732623B (en) | 2009-12-08 | 2009-12-08 | Medicament for treating acute gouty arthritis and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101732623B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104367770A (en) * | 2014-09-29 | 2015-02-25 | 洛阳御平国生物科技有限公司 | Formula of traditional Chinese medicine for treating gouty arthritis |
CN104758920A (en) * | 2015-04-29 | 2015-07-08 | 唐凯 | Gout health care product based on homology of medicine and food |
CN105943958A (en) * | 2016-06-03 | 2016-09-21 | 黑龙江省玄鸟生物科技股份有限公司 | Inonotus obliquus composite solid particles for treating gout and preparing method thereof |
CN106421555A (en) * | 2016-09-27 | 2017-02-22 | 余泽恒 | Chinese herbal medicinal liquor and preparation method thereof |
-
2009
- 2009-12-08 CN CN2009102205255A patent/CN101732623B/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN101732623A (en) | 2010-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100531769C (en) | Chinese medicine composition for treating gout and preparing method thereof | |
CN102028900B (en) | Traditional Chinese medicine for treating metabolic syndrome and preparation method thereof | |
CN101700358B (en) | Medicine for treating acute and chronic nonspecific ulcerative colitis and preparation method thereof | |
CN101732623B (en) | Medicament for treating acute gouty arthritis and preparation method thereof | |
CN102188634B (en) | Chinese medicine composition for treating hyperuricemia | |
CN102813870B (en) | Chinese herbal compound preparation used for treating alcoholism and gout and preparation method and application thereof | |
CN102631595A (en) | Medicament for treating II-type diabetes mellitus and preparation method thereof | |
CN101850065B (en) | Chinese medicinal composition for treating gout | |
CN102430009B (en) | Traditional Chinese medicinal composition for treating gastrointestinal disease and preparation method thereof | |
CN101152450B (en) | Dysuria releasing tablet and method for preparing the same | |
CN102430008B (en) | Chinese medicinal composition for treating gastrointestinal disease and preparation method thereof | |
CN101837093A (en) | Chinese medicinal composition for curing gout | |
CN103919895B (en) | The Chinese medicinal liquor of a kind of the intestines and stomach coordinating, treatment constipation | |
CN102274428B (en) | Pharmaceutical composition with effect on treating irritable bowel syndrome and preparation method and application thereof | |
CN101700296A (en) | Chinese herbal preparation for curing gastroenteritis and preparation method thereof | |
CN105833043A (en) | Application of traditional Chinese medicine composition in preparation of medicine for treating primary hypertension | |
CN104257803A (en) | Pharmaceutical composition for treating snore as well as preparation method and application of pharmaceutical composition | |
CN105232754A (en) | Medicine for treating type-II diabetes | |
CN103479763A (en) | Traditional Chinese medicine composition for treating borderline hypertension and preparation method thereof | |
CN104225034B (en) | Application of composition in preparing medicine for treating non-infectious urethral syndrome | |
CN114191513B (en) | Traditional Chinese medicine composition for treating damp-heat type obesity | |
CN102366540A (en) | Medicine for treating diabetes and its preparation method | |
CN102600436A (en) | Traditional Chinese medicine compound preparation for treating gastric cancer and preparation method thereof | |
CN110448626B (en) | Traditional Chinese medicine compound for treating gout and preparation method and application thereof | |
CN101810782B (en) | Medicament for treating diabetes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhang Xiaoming Inventor after: Bi Zhequan Inventor before: Bi Zhequan |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: BI ZHEQUAN TO: ZHANG XIAOMING BI ZHEQUAN |
|
ASS | Succession or assignment of patent right |
Owner name: ZHENG HONGMEI Free format text: FORMER OWNER: BI ZHEQUAN Effective date: 20130806 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20130806 Address after: 114001, Anshan Province, Qianshan District, Liaoning Province Road, Wan Sheng new Korean Village (Xiao Dynasty) 442 Patentee after: Zheng Hongmei Address before: 114001, eleven East Street, 2 iron street, Liaoning, Anshan Patentee before: Bi Zhequan |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110504 Termination date: 20161208 |
|
CF01 | Termination of patent right due to non-payment of annual fee |